Skip to content
Surf Wiki
Save to docs
general/25-nb-psychedelics

From Surf Wiki (app.surf) — the open knowledge base

25TFM-NBOMe

Chemical compound


Chemical compound

25TFM-NBOMe (also known as NBOMe-2C-TFM, 2C-TFM-NBOMe, and Cimbi-138) is a derivative of the phenethylamine hallucinogen 2C-TFM, discovered by Ralf Heim at the Free University of Berlin by 2000. It can be taken to produce psychedelic effects similar to 25I-NBOMe and 25D-NBOMe.

Interactions

Pharmacology

Pharmacodynamics

TargetAffinity (Ki, nM)
[5-HT1A](5-ht1a-receptor)ND
[5-HT1B](5-ht1b-receptor)ND
[5-HT1D](5-ht1d-receptor)1,817
[5-HT1E](5-ht1e-receptor)ND
[5-HT1F](5-ht1f-receptor)ND
[5-HT2A](5-ht2a-receptor)0.35–0.49 (Ki)
0.96–2.0 ()
80–92% ()
[5-HT2B](5-ht2b-receptor)1.1 (Ki)
ND (EC50)
ND (Emax)
[5-HT2C](5-ht2c-receptor)2.7 (Ki) (rat)
11.5 (EC50)
110% (Emax)
[5-HT3](5-ht3-receptor)ND
[5-HT4](5-ht4-receptor)ND
[5-HT5A](5-ht5a-receptor)8,128
[5-HT6](5-ht6-receptor)23.4
[5-HT7](5-ht7-receptor)5,974
α1A–α1DND
α2A–α2CND
β1–β3ND
D1–D5ND
H1–H4ND
M1–M5ND
I1ND
σ1, σ2ND
ORsND
ND
ND (Ki)
ND ()
ND (EC50)
ND (Ki)
ND (IC50)
ND (EC50)
ND (Ki)
ND (IC50)
ND (EC50)
**Notes:** The smaller the value, the more avidly the drug binds to the site. All proteins are human unless otherwise specified. **Refs:**

25TFM-NBOMe acts as a potent partial agonist for the serotonin 5-HT2A receptor, though its relative potency is disputed, with some studies finding it to be of lower potency than 25I-NBOMe, while others show it to be of similar or higher potency, possibly because of differences in the assay used.

History

25TFM-NBOMe was first described in the scientific literature by Ralf Heim and colleagues at the Free University of Berlin by 2000.

Society and culture

Canada

25TFM-NBOMe is a controlled substance in Canada under phenethylamine blanket-ban language.

United Kingdom

References

References

  1. (2004). "Synthese und Pharmakologie potenter 5-HT2A-Rezeptoragonisten mit N-2-Methoxybenzyl-Partialstruktur. Entwicklung eines neuen Struktur-Wirkungskonzepts".
  2. (2010). "Serotonin receptor studies in the pig brain: pharmacological intervention and positron emission tomography tracer development". Faculty of Health Sciences, University of Copenhagen.
  3. (2010-12-16). "Design and Synthesis of Selective Serotonin Receptor Agonists for Positron Emission Tomography Imaging of the Brain". University of Copenhagen.
  4. (April 2011). "Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT (2A) agonist PET tracers". European Journal of Nuclear Medicine and Molecular Imaging.
  5. (19 March 2014). "Synthesis and Structure–Activity Relationships of N -Benzyl Phenethylamines as 5-HT 2A/2C Agonists". ACS Chemical Neuroscience.
  6. (2009). "Theoretical study of the interaction of agonists with the 5-HT2A receptor.". Universität Regensburg.
  7. (January 2011). "Theoretical studies on the interaction of partial agonists with the 5-HT2A receptor". Journal of Computer-aided Molecular Design.
  8. (April 2011). "Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT (2A) agonist PET tracers". European Journal of Nuclear Medicine and Molecular Imaging.
  9. (2010-12-16). "Design and Synthesis of Selective Serotonin Receptor Agonists for Positron Emission Tomography Imaging of the Brain.". University of Copenhagen.
  10. (2000). "Partial 5-HT2A-receptor agonists of the phenylethanamine series: effect of a trifluoromethyl substituent.". Arch. Pharm. Pharm. Med. Chem.
  11. "Controlled Drugs and Substances Act".
Info: Wikipedia Source

This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.

Want to explore this topic further?

Ask Mako anything about 25TFM-NBOMe — get instant answers, deeper analysis, and related topics.

Research with Mako

Free with your Surf account

Content sourced from Wikipedia, available under CC BY-SA 4.0.

This content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.

Report